MYCN and neoplasm: Moreover, CB5 + VP16 demonstrated enhanced effects on tumor cell proliferation and apoptosis (p ≤ 0.05, Supplementary Fig. 6d–e) without further reducing MYCN expression compared with CB5 alone (Supplementary Fig. 6f) and with no evidence of body weight loss or normal organ toxicity (Supplementary Fig. 6g).